Almeida et al. (2014) report that cisplatin-resistant cells have active NFκB signaling and inhibition of NFκB translocation to the nucleus enhances apoptosis in head and neck squamous cell carcinoma [65]. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.